Activities, Bill Numbers and Titles
|
|
Client: Amgen Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $360.58
|
House Bill
|
1205
|
An Act relative to prescription drug price transparency
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
616
|
An Act relating to patient cost, benefit and coverage information, choice, and price transparency
|
Oppose
|
$0.00
|
n/a
|
House Bill
|
945
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
n/a
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Oppose
|
$0.00
|
n/a
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|